Products
|
|
| |
Home » Products » Natricin
rifampicin
Natricin® Forte
FORMULATION:
Each 5mL Natricin Forte suspension contains................ 200mg
Does not contain sodium metabisulfite.
INDICATIONS:
Tuberculosis in all forms, leprosy, infections caused by rifampicin-sensitive microorganisms e.g. Staphylococci and Neisseria gonorrhea; asymptomatic carriers of N. meningitides.
CONTRAINDICATIONS:
Presence of jaundice; history of hypersensitivity reaction to any of the rifampicins.
Severe liver damage.
WARNINGS:
Rifampicin has been shown to produce liver dysfunction. Since an increased risk may exist for individuals with liver disease, benefit must be weighed carefully against any risk of further liver damage. Periodic liver function monitoring is mandatory.
USAGE IN PREGNANCY:
Teratogenicity of rifampicin in humans has not been reported. However, rifampicin is reported to cross-placental barrier although effect of the substance on the human fetus is not known.
Before starting the treatment with natricin, please inform your doctor if you are pregnant or expecting pregnancy. If possible, Natricin Forte should not be taken in the first 3 months of pregnancy.
The reliability of oral contraceptives may be affected by rifampicin. Alternative contraceptive may be considered.
ADVERSE EFFECTS:
Rifampicin is usually well tolerated. Adverse effects are common during intermit-tent therapy or after starting interrupted treatment.
Hypersensitivity reactions have been reported. Occasionally pruritis, rash, sore mouth and tongue, urticaria, and exudative conjunctivitis are manifested. Gastrointestinal disturbances, fever and generalized numbness, allergic immuno-logic reactions are rare. Administration on an empty stomach is recommended for
|
|
